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Quantitative Estimation of Tissue Blood Flow Rate 
 
Gillian M Tozer, Vivien E Prise and Vincent J Cunningham 
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Abstract 
 
The rate of blood flow through a tissue (F) is a critical parameter for assessing 
the functional efficiency of a blood vessel network following angiogenesis. This 
chapter aims to provide the principles behind the estimation of F, how F relates 
to other commonly used measures of tissue perfusion and a practical approach 
for estimating F in laboratory animals, using small readily diffusible and 
metabolically inert radio-tracers. The methods described require relatively non-
specialized equipment. However, the analytical descriptions apply equally to 
complementary techniques involving more sophisticated non-invasive imaging. 
Two techniques are described for the quantitative estimation of F based on 
measuring the rate of tissue uptake following intravenous administration of 
radioactive iodo-antipyrine (or other suitable tracer). The Tissue Equilibration 
Technique is the classical approach and the Indicator Fractionation Technique, 
which is simpler to perform, is a practical alternative in many cases. The 
experimental procedures and analytical methods for both techniques are given, 
as well as guidelines for choosing the most appropriate method. 
 
Key Words: backflux, blood flow rate, cannulation, distribution volume, indicator 
fractionation, iodo-antipyrine, partition coefficient, radiotracer, tissue equilibration  
 
 
 
 
 
1. Introduction 
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The maturation phase of angiogenesis results in a functional blood vessel 
network. In established tumours, this network is abnormal but nevertheless 
sufficient to support tumour growth and metastasis. Blood flow rate through the 
vascular network is a measure of its functional efficiency, knowledge of which is 
central to understanding the angiogenic process. Its quantitative estimation 
provides the basis for determining oxygen, nutrient and drug delivery to tissue 
(see Note 1). In pathological angiogenesis, such as in tumours, blood flow rate is 
the most sensitive and relevant pharmacodynamic end-point for determining the 
efficacy of drugs designed to disrupt blood vessel function. Therefore, estimation 
of blood flow rate is essential for both basic studies of the angiogenic process 
and applied studies of the effects of therapy. This chapter aims to provide the 
principles behind, and a practical approach to, the quantitative estimation of 
blood flow rate in experimental mice and rats .  
 
Blood flow rate is the rate of delivery of arterial blood to the capillary beds within 
a particular mass of tissue. It is typically measured in units of mls of blood per g 
RIWLVVXHSHUPLQXWHPOEORRGJWLVVXH-1PLQ-1), or, alternatively, per unit 
YROXPHRIWLVVXHPOEORRGPOWLVVXH-1PLQ-1). 
 
The average time taken for blood to pass through a particular capillary bed 
(capillary mean transit time (W) is the parameter that relates tissue blood flow rate 
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()LQPOJ-1PLQ-1) to fractional blood volume of the tissue (9LQPOJ-1). This 
classical relationship is known as the central volume principle (1):   
W  9)««««««««««(TXDWLRQ 
For different tissues, F can vary widel\IRUH[DPSOHLWLVDSSUR[LPDWHO\POJ-
1PLQ-1 LQUDWVNLQDQGPOJ-1PLQ-1 in rat kidney. From Equation 1 and using a 
value for V RIPOJ-1 IRUVNLQDQGPOJ-1 for kidney, W is approximately 18 
s and 0.9 s respectively for these tissues. From Equation 1, W is only indirectly 
proportional to F, if V is constant, and so neither W nor V can be used to estimate 
F unless they are both measured simultaneously. The same considerations apply 
to parameters related to W, such as red blood cell velocity (RBC velocity) and the 
blood supply time (BST); see below. 
 
In order to estimate F, the most accurate approach is to measure the rate of 
delivery of an agent carried to the tissue by the blood. A contrast agent is 
injected into the blood-stream, its concentration time-course in arterial blood 
(input function) together with the kinetics of its uptake into tissue (tissue response 
function) are measured. F is then estimated from a mathematical model relating 
the tissue response function to the input function (see below). The contrast agent 
can be radio-active, whereby tissue concentrations can be measured by gamma 
or scintillation counting or by an external imaging system (e.g. a positron emitter 
for positron emission tomography). Alternatively, a contrast agent that is suitable 
for external magnetic resonance imaging, computed tomography or ultrasound 
imaging can be used. Radio-active agents have the advantage that they can be 
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administered at true tracer concentrations, therefore not interfering with 
physiological processes, and they do not necessarily need sophisticated imaging 
technology. 
 
Some common methods for determining blood perfusion parameters are given 
below, most of which do not provide fully quantitative estimates of the blood flow 
rate, F: 
1. Intravital microscopy (see Chapters X and X) is a specialised technique that 
enables direct visualisation of tissue microcirculation, usually via surgically 
implanted transparent chambers or single-sided windows. This enables 
measurement of RBC velocity (PV-1) in individual capillaries, as well as the 
blood supply time (BST, defined below). RBC velocity is measured either by 
directly tracking individual fluorescently labelled red blood cells through vessel 
segments (2) or matching the interference patterns of light reaching a camera 
through a slit system (3). Modern computing techniques now enable 
comparison of optical signals at individual spatial locations with those in 
neighbouring locations over time, so that 2-dimensional maps of both speed 
and direction of blood flow can be constructed, based on similar principles to 
the classical slit system approach (4). Measurements can be combined with 
measurements of red cell flux (number of red blood cells traversing a vessel 
segment per unit time) to calculate microvascular haematocrit (5) or with 
morphological measurements of individual blood vessel segments to obtain 
HDFKVHJPHQW¶Vvolume flow rate (Fseg), which assumes that RBCs are 
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traveling with the bulk plasma flow (6). Measurement of BST has been carried 
out in intravital studies of tumours, from images of the tumour vascular 
network over time, following the intravenous injection of a fluoresecent marker 
such as TRITC-dextran (7). For each pixel of the vascular image, BST is 
defined as the time difference between the frame showing maximum 
fluorescence intensity and the frame showing maximum fluorescence intensity 
in a tumour-supplying artery, during a short timescale following intravenous 
injection. Both RBC and BST provide functional information on tumour 
perfusion but are not directly related to F, as discussed above.   
2. Laser Doppler flowmetry (LDF) provides a means of estimating relative 
changes in red cell velocity e.g. following treatment, via surface or tissue-
inserted probes. This measures a frequency shift in light reflected from moving 
red cells, which is a measure of average red cell velocity (8). Again, it should 
be noted that changes in red cell velocity may not accurately reflect changes 
in F.  
3. The fluorescent DNA-binding dye, Hoechst 33342, and certain carbo-cyanine 
dyes are examples of rapidly binding agents that have been used to determine 
DµSHUIXVHGYDVFXODUYROXPH¶DVDIUDFWLRQRIWKHWRWDOWLVVXHYROXPHUDWKHU
than blood flow rate per se. This method has been used especially in tumour 
studies (9, 10)}. In this case, tissues are excised after several circulation 
times, following intra-venous injection of the dye, and functional vessels 
appear in tissue sections as fluorescent halos. Alternatively, a fluorescently 
tagged lectin that rapidly binds to endothelial cells in vivo can be used (11). 
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Conventional Chalkley point counting (12, 13) or image analysis provides the 
fractional tissue volume occupied by fluorescence. This is a useful measure of 
vascular function in many circumstances but is insensitive because it cannot 
discriminate between perfused vessels with different flow rates. 
4. For contrast agents that are confined to the blood-stream, methods based 
on Equation 1 can be used to calculate F (14). However, this is difficult in 
practice because W is only a few seconds, requiring highly sensitive techniques 
IRULWVPHDVXUHPHQW5DGLRDFWLYHRUFRORXUHGµPLFURVSKHUHV¶RIGLDPHWHUV
around 15 - 25 µm are a special class of contrast agents that are confined to 
the blood-stream because they should be trapped on first-pass through tissue. 
Therefore, following injection directly into a major artery, they distribute to 
tissues in direct proportion to the fraction of the cardiac output received by the 
tissues, enabling calculation of blood flow rate (15). With this technique, care 
needs to be taken to ensure adequate mixing of the microspheres in the 
arterial blood (which is challenging in mice, for instance) and enough 
microspheres are lodged in the tissue regions of interest to obtain statistical 
validity. In the case of tumours, care needs to be taken to determine and 
correct for microspheres that are re-circulated due to lack of trapping in large 
diameter vessels (16, 17).  
5. The principles used to calculate blood flow rate using microspheres can 
sometimes be used even when the indicator crosses the vascular wall into the 
tissue and re-circulates after the first pass through the tissue. If the tissue 
concentration of the indicator reaches a constant level that is maintained for 
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the first minute or so after injection, this indicates that the extraction fraction by 
the tissue is equal to that of the whole body (18). The fractional uptake of the 
indicator into the tissue must therefore equate to the blood flow fraction of the 
cardiac output received. In the original description of the technique, potassium 
DQGUXELGLXPFKORULGHEHKDYHGDVµSVHXGR-PLFURVSKHUHV¶LQPRVWQRUPDO
tissues, with the notable exception of brain (18). 
6. Small, lipid-soluble, metabolically inert molecules, which rapidly cross the 
vascular wall and diffuse through the extra-vascular space, are also useful as 
blood flow markers. In this case, the fraction of marker crossing the capillary 
vascular wall from the blood in a single pass through the tissue (extraction 
fraction, E) is close to 1.0 and for fully perfused tissue the accessible volume 
fraction (D)of the tissue is also close to 1.0. The inert radioactive gas, 
133Xenon, or hydrogen can be administered by inhalation (19, 20). However, 
safety issues with 133Xenon and the necessity for tissue insertion of 
polarographic electrodes for hydrogen have limited their use. A practical 
approach, which has utility for accessing the spatial heterogeneity of tissue 
blood flow rate, is the intravenous administration of a small, lipid soluble, inert 
molecule dissolved in saline. In this case, net uptake rate into tissue over a 
short time (seconds) after intra-venous injection is determined primarily by 
blood flow rate. Methods for quantitative estimation of tissue blood flow rate 
and related parameters using these agents are described below (see Note 2). 
 
2. Materials 
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2.1 Radioactive tracer preparation 
1. Any small, lipid soluble molecule that can be suitably labelled and is not 
metabolized in tissue over the short time of the experiment can be used. 
Suitable radio-isotopes include 125I and 14C, where tissue and blood 
counts can be obtained using standard techniques and autoradiography 
/phosphor imaging can be applied if spatial variation in blood flow rate 
across a tissue of interest is required (see Note 3).  
2. One that has been used commonly for both normal tissue studies 
(primarily brain (21)) and tumour studies (22) is iodo-antipyrine (IAP) 
(Figure 1). 125I-IAP is commercially available, for example from MP 
Biomedicals and 14C-IAP (4-Iodo[ N-methyl -14 C]antipyrine) from 
PerkinElmer. Alternatively, a technique for labelling IAP with 125I is 
described by Trivedi (23) (see Note 4).  
 
2.2 Animal preparation 
Large vessel cannulation is required for intravenous administration and arterial 
blood sampling. Materials required:  
1. general anaesthetic  
2. heparinised saline for cannulae (add 0.3ml of 1000U/ml heparin to 10ml 
saline) 
3. general surgical equipment plus fine angled forceps, small spring scissors, 
microvascular clip. 
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4. polythene tubing cut to suitable lengths, size appropriate to that of the 
vessel being cannulated (e.g. for rat 0.58mm internal diameter; 0.96mm 
outside diameter). 
5. dissecting microscope 
6. cold light source 
7. thermostatically controlled heating blanket, with rectal thermometer 
 
2.3 Blood flow assay 
1. 125I-labelled IAP (125I-IAP) and suitable protective equipment 
2. minimal dead-space glass syringe 
3. general dissecting instruments for excising tissue 
4. stop-clock 
5. lidded container containing saline-soaked gauze 
6. gamma counter and suitable vials for tissue and blood samples 
7. analytical balance 
8. anaesthetic (see Note 5) 
9. fraction collector set to collect at 1 second intervals 
10. syringe pump for infusion and withdrawal 
11. 1000U/ml heparin (use neat for rats and diluted 1 in 10 with saline for 
mice). 
12. injection saline 
13. high concentration solution of sodium pentobarbitone e.g. EuthatalTM  
 
3. Methods 
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3.1 Animal preparation  
In the rat, a tail artery and vein are most suitable for cannulation. In the mouse, 
either the carotid artery and jugular vein or femoral artery and vein can be used. 
 
1. Prepare 30 cm lengths of cannulae. For rat use 0.96 mm outside diameter 
(o.d.); 0.58 mm internal diameter (i.d.). The cannula wall may be shaved 
down at the tip and the end may be slightly bevelled to aid insertion. Use a 
microscope to ensure that there are no sharp edges. For mouse use a 
short length of 0.61 mm o.d.; 0.28 mm i.d. cannula, stretched to a smaller 
diameter at the tip and connected to a longer length of 0.96 mm o.d.; 0.58 
mm i.d. cannula to reduce resistance to flow. Attach each length to a 1 ml 
syringe filled with heparinised saline.  
2. Anaesthetize the animal, insert rectal thermocouple and place on heating 
blanket. Also, an overhead lamp is a useful additional heat source.  
3. Illuminate surgical area with a cold light source.  
4. Expose the relevant vessel. For the rat tail, this involves making two 2 cm 
incisions through the skin, each side of the vessel, approximately 5 mm 
apart and approximately 2 cm from the base of the tail. Use artery forceps 
to clear the skin from the underlying connective tissue and cut the skin at 
the distal end to create a flap (see Note 6). 
5. Keep exposed vessels moist at all times using warmed saline.  
6. Free the vessel from surrounding connective tissue using fine blunt-end 
forceps. 
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7. Place two lengths of suture under the vessel, tying off the most distal to 
the heart, which can be used to apply slight tension to the vessel.  
8. Occlude the vessels as far proximal as possible using a microvascular 
clip.  
9. Using spring scissors, make a v-shaped cut in the vessel close to the 
distal knot and insert cannula. Advance cannula into the vessel 
approximately 2 cm or more, by removing clip (see Note 7). 
10.  Aspirate gently to ensure that blood is free flowing. It may not be possible 
to aspirate the vein but a small volume of saline can be injected to check 
for patency.  
11. Tie both sutures securely around the cannula. Use tape or tissue-
compatible glue to secure the cannula to the skin distal to the distal 
suture. Close the wound.  
 
3.2 Blood flow assay 
Two alternatives are described; the classic tissue equilibration method for rats 
and the indicator fractionation method for rats or mice. Graham et al (24) directly 
compared results obtained with these two techniques in a rat brain tumour model 
and the main advantages and disadvantages of each method are given in Table 
1.  
 
3.2.1 Tissue equilibration technique 
Cannulation of two tail veins and one tail artery are required, as described above. 
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1. Remove 125I-IAP from the freezer and bring slowly to room temperature. 
Using suitable containment and a low dead-space glass syringe, carefully 
remove required volume 125I-IAP (0.2 ± 0.3 MBq per rat) and dispense into 
a vial.  
2. Evaporate the methanol using a very gentle stream of nitrogen and slowly 
add injection saline to the 125I-IAP (0.8ml per rat plus extra to account for 
syringe dead spaces etc). Gently mix. 
3. Load a syringe of size suitable for infusion with the 125I-IAP solution 
(needle must be suitable size for the venous cannula). 
4. For anaesthetized animals, keep warm, as described above. Check 
arterial blood pressure and heart rate by connecting the arterial cannula to 
a pressure transducer and recording device. Then clamp off the cannula 
and connect it to the fraction collector, loaded with pre-weighed glass 
tubes, for subsequent blood collection. 
5. Inject and flush in 0.1ml neat heparin (= 100 I.U.) via one of the venous 
cannulae to ensure the blood flows freely from the arterial cannula. 
6. Cut one of the venous cannulae to approx. 3 cm in length and connect a 
syringe containing approx. 0.5ml EuthatalTM$VPDOO³7-FRQQHFWRU´PD\
also be used to allow drug administration via this cannula.  
7. Set syringe pump speed to 1.6 ml/min (see Note 8). Carefully place the 
125I-IAP-containing syringe in the pump and connect it to the second 
venous cannula. 
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8. Start the stop-clock and unclamp the artery, checking that blood is free-
flowing. At 5 s, start syringe pump and fraction collector (see Note 9). At 
35 s, inject EuthatalTM and stop pump; rapidly excise tissues of interest 
and stop fraction collector (see Note 10).  Place tissues in the lidded 
container to prevent drying. Weigh the blood tubes and cap them. Weigh 
the tissues and place them in gamma counting tubes. 
9. Count the blood and tissue samples on the gamma counter. 
 
3.2.2 Indicator fractionation technique 
Cannulations of one artery and two veins are required. Alternatively, cannulae 
attached to shafts of hypodermic needles can be inserted into tail veins 
percutaneously instead of cannulating veins.  
1. Follow points 1-3 above, preparing 0.07 MBq 125I-IAP in 0.05 ml saline per 
mouse. 
2. For anaesthetized animals, keep warm, as described above. Check 
arterial blood pressure and heart rate by connecting the arterial cannula to 
a pressure transducer and recording device. 
3. Set syringe pump speed to 150µl/min (mouse) or 1.6 ml/min (rat). 
4. Load a 250µl syringe (for mouse) or 2 ml syringe (for rat) with approx 
100µl saline, attach a 23G needle and position in the pump. 
5. Cut the venous cannula as short as possible and inject 0.05ml of diluted 
heparin ({ 5 I.U.) for mouse or 0.1 ml neat heparin ({ 100 I.U.) for rat. 
Disconnect heparin syringe and attach 125I-IAP syringe and a syringe 
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containing injection saline via a T-piece. Connect syringe containing 
EuthatalTM to second venous cannula. 
6. Clamp the artery cannula, disconnect it from the pressure transducer, and 
connect it to the syringe pump. Ensure that the pump is set to withdraw 
and allow it to withdraw very briefly to ensure that the cannula is patent 
and the syringe is positioned correctly. 
7. Start the stop-clock and pump simultaneously. Check that the blood is 
flowing freely. At 3 s, inject 0.05 ml of 125I-IAP for mouse or 0.2 ml for rat, 
as a rapid bolus via the venous cannula, followed immediately by 0.05 ml 
saline from the second syringe. At 13 - 18 s (see Note 11), inject 
EuthatalTM and immediately pull out full length of arterial cannula and 
excise the tissue of interest. All the blood should be retained in the 
cannula. Place the tissue in a pre-weighed gamma counting tube.  
8. Attach a saline filled syringe to the arterial cannula and eject all the blood 
into a gamma counting tube together with 1ml of saline.  
9. Count the blood and tissue samples on the gamma counter. 
 
3.3 Blood flow analysis 
3.3.1 Tissue equilibration technique 
1. Analysis is based on a model which assumes a vascular compartment from 
which the input function derives and a single (extra-vascular) well-mixed tissue 
compartment (Figure 1). A small, highly soluble and inert tracer, such as IAP, 
is assumed to rapidly equilibrate between all blood components and the tissue 
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compartment. In this case, the model based on Kety (25) describes the 
relationship between the tissue concentration of the tracer at time t, Ct(t), and 
the arterial blood concentration of the tracer at time t, Ca(t), by the Equation: 
Ctiss(t) = k1Ca(t) 8 exp(-k2t) «««««««Equation (2) 
where k1 is tissue blood flow rate (F) and k2 is k1 / DO; D is the effectively 
perfused fraction of tissue (i.e. the fraction of tissue that is immediately 
accessible to the tracer) and O is the equilibrium partition coefficient of the 
tracer between tissue and blood; 8 denotes the convolution integral; in 
imaging studies, DO is often referred to as the apparent volume of distribution 
(VDapp) of the tracer in the tissue (26), Ctiss(t) and Ca(t) are expressed in 
radioactivity counts per g tissue and per ml blood respectively, using 1.05 for 
the density of blood. 
  
2. In this method, Ctiss(t) is measured at only one time-point i.e. after tissue 
excision. Hence only one parameter, k1 (F) can be estimated from the data 
(see Note 12). O is approximated from literature values or estimated from 
separate experiment (27) and D is taken as 1.0 (see Notes 12 and 13). 
Studies have shown that the method is relatively insensitive to small changes 
in O
 
because of the short time-scale of the experiment (28). Also see Table 1. 
6ROYLQJ(TXDWLRQ'DWDFDQEHILWWHGWR(TXDWLRQXVLQJDVLPSOHµ7DEOH
/RRNXS0HWKRG¶,QWKLVPHWKRGVLQFHWKHLQSXWIXQFWLRQLVNQRZQWKHQWKH
expected tissue activity at the time of excision Ctiss (T) can be calculated for 
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each of a range of realistic values of F, using Equation (2). Direct comparison 
of the observed Ctiss (T) against the table then gives the required estimate of F 
(Figure 2). Evaluation of the Integral in Equation (2) requires a numerical 
integration routine, which are commonly available in statistical analysis 
packages, or can be programmed using computer applications such as 
MATLAB (The Mathworks, USA ©). A further issue, which needs to be taken 
into account when assessing the accuracy of this type of technique, is the 
possibility that the input function time course may not be accurately measured 
because of a time delay between the radioactivity reaching the tissue and 
reaching the blood collection tubes and because of smearing or dispersion 
effects occurring on the arterial cannula before blood collection. These delay 
and dispersion effects can be corrected for (see Note 14) but do add further 
complication to the analysis. 
 
3.3.2 Indicator Fractionation technique 
1. This method was first used by Goldman & Sapirstein (29), with later 
modifications (30). It simplifies the model used in Equation 2 by assuming that 
the backflux of the tracer from tissue into the blood is negligible compared with 
its influx into the tissue, for a short period of time after injection of the tracer 
(see Note 15). Under these conditions, Equation 2 reduces to: 
k1 = Ctiss(T) / ³0TCaWGW«««««««(TXDWLRQ 
where k1, t, Ca(t) are as defined above and Ctiss(T) is concentration of tracer in 
the tissue at the end of the experiment (at time t = T). 
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2. T is typically set at 10 ±15 seconds, during which time collection of sufficient 
blood samples, as described for the tissue equilibration technique, is difficult. 
Instead, the constant withdrawal technique can be used. Here, blood is 
withdrawn from an artery at a constant rate using a pump from t = ±7¶to t = T, 
where ±7¶ is the time at which the pump is started. A bolus injection of tracer is 
given at t = 0. Under these conditions,  
³0TCa(t)dt = Cc 77¶ &cVbU ;U«««««(TXDWLRQ 
where Cc is mean concentration of tracer in the blood sample; Vb is volume of 
blood collected; X is total radioactive counts in the collected blood sample and 
r is rate of withdrawal of blood. 
 
3. X/r can be substituted into Equation 3 and blood flow rate, k1, can be 
calculated from a knowledge of the counts, X, pump rate, r, and concentration 
of the tracer in the tissue at the end of the experiment, Ctiss (T). As for the 
tissue equilibration technique, there are inaccuracies in the measurement of 
the input function using this technique, associated with delay and dispersion 
along the plastic cannula. However, the constant withdrawal method means 
that definition of a concentration-time curve is not required and only the last 
part of the actual arterial time-course is lost by the blood sampling method. In 
addition, the experimental set-up of the indicator fractionation method means 
that the arterial cannula can be kept short, minimizing the delay involved. 
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3.3.3 Comparison of the two blood flow methods 
The advantages and disadvantages of the classic tissue equilibration method 
and the indicator fractionation method are summarized in Table 1. Patlak et al. 
(28) carried out an evaluation of errors involved in the two techniques, which 
can be summarized as follows: 
1. Errors in the tissue equilibration method are minimized if an optimal 
infusion schedule is used (a ramped schedule is best but a constant 
infusion is reasonable), timing is measured precisely and corrections are 
made for delay and dispersion. Under these conditions, 10-15% inaccuracy 
in the value used for O is well tolerated in the calculation of F. If precise 
measurement of O can be made, this is the method of choice. 
2. If O cannot be measured reasonably accurately, the indicator fractionation 
technique maybe the better option for estimating F. Errors associated with 
backflux are minimized by a short experimental time. Errors associated 
with imprecise timing are minimized by bolus administration of the tracer 
(so that arterial concentration is low at tissue excision). The constant 
withdrawal method is an added advantage for its simplicity and accuracy. 
However, backflux cannot be completely prevented (especially with bolus 
administration) and may introduce significant errors where F is high and/or 
D is low. Delay and dispersion effects are reasonably well tolerated.  
3. Both techniques require accurate measurement of tracer concentration in 
the tissue (Ctiss). 
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4. Notes 
 
1. The methodology presented here is based on a single tissue compartment 
model. This can be derived from the classic Renkin-Crone unit capillary 
model (31, 32), which gives an explicit relationship between flow, the 
extraction of substances from blood into tissue and the mean permeability 
surface area product of the capillary bed. Recent simulation studies show 
that the degree of local heterogeneity in capillary architecture and transit 
times of blood through the capillaries may also affect the precise 
relationship between flow and extraction of substances from the blood into 
tissue (33, 34). 
2. The basic experimental principles and analytical methods described here 
also apply to various external imaging techniques that are now available 
for use in small animals e.g. positron emission tomography (35). These 
techniques allow repeated evaluation of blood flow rate (and other 
pharmacodynamic end-points) in the same animal, as long as the 
biological and radioactive half-lives of the tracer are compatible with the 
time-scale of the experiment. In addition they allow definition of more than 
one vascular parameter (see note 12 below). 
3. Instead of obtaining a single value for the blood flow rate within a tissue 
(usually by calculating Ctiss from gamma counts of tissue activity), the 
variation of blood flow rate within a tissue can be obtained at high spatial 
resolution (~ 50 µm) by using a radiotracer that is suitable for 
autoradiography or phosphor imaging (Figure 2). In these cases, Ctiss is 
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obtained in raster fashion across tissue sections for calculation of 
corresponding k1  (F) values (36).   
4. Local radiation safety procedures need to be followed for all the 
techniques described to avoid contamination of personnel and equipment.  
5. General anaesthesia seriously affects mean arterial blood pressure in 
rodents, especially in mice, and its effects on tissue blood flow rates need 
to be considered in planning experiments. Animals can be allowed to 
recover from general anaesthesia induced by inhalational anaesthetics 
following cannulation but, in this case, procedures for preventing cannula 
disturbance and minimising pain and distress to the animals need to be 
implemented (37). 
6. Tail cannulations: the tail artery lies relatively deep within a cleft in the 
cartilage and requires an incision to be made through the overlying 
connective tissue for it to be accessible. Once freed it is robust for 
cannulation; the vein is much more superficial and easily located, although 
more fragile than the artery and liable to constriction and tearing. 
7. A topical vasodilator such as procaine can be used to aid cannula 
insertion.  
8. Volumes of saline solutions of IAP for intravenous administration are 
chosen to compensate for rate of blood loss during the course of the 
experiments. 
9. A constant infusion schedule for delivery of the radiotracer is described, as 
it is simple to achieve in practice. However, an infusion schedule that 
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increases with time (ramped) could be employed because this reduces the 
influence of an incorrect value for O, on the calculated value of F (28). The 
movement of the fraction collector and the infusion/withdrawal rates of the 
pump need to be carefully calibrated prior to experiments. 
10. Timing errors can be significant if blood flow to tissues of interest is not 
stopped at the instant that the pump is stopped. Also see Table 1. 
11. A short duration increases timing errors but a longer one increases errors 
associated with backflux of the tracer from the tissue into blood. Also see 
Table 1. 
12. A disadvantage of this particular technique is that the tissue concentration 
of the tracer is assayed at only one time point. Hence, as noted above, 
only one parameter (F) can be estimated, whereas values for D and O 
have to be assumed. Other, more sophisticated techniques involving non-
invasive imaging, such as PET (see note 2), involve a full time course of 
the tissue to be assayed, allowing estimation of DO (VDapp) for example, as 
well as F.  This is of particular interest in the case of tumour blood flow, 
where the effectively perfused tissue fraction (D) (i.e. the fraction of tissue 
that is immediately accessible to the tracer) is often less than 1.0 because 
of large intercapillary distances or ischaemic regions (26). However, the 
spatial resolution of non-invasive imaging cannot compete with the high 
spatial resolution achievable with the invasive techniques described here 
(see note 3). In the invasive technique, D is usually assumed to be 1.0. If it 
is actually less than 1.0, for a sampled tissue region of interest, the 
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measured tissue concentration of the tracer, Ctiss, will be low because it is 
averaged over the whole region, including the inaccessible part. Thus the 
calculated value of F will reflect average blood flow for the region and 
underestimate that of the perfused tissue fraction. 
13. Beyond the short time-scale of these experiments, IAP redistributes in 
tissue in a space-dominated rather than a flow-dominated pattern. At 
equilibrium, IAP might be expected to distribute in proportion to the tissue 
water content, such that O would be similar in all tissues and close to 1.0. 
However, experimental evidence indicates that, although O for IAP is close 
to 1.0 in many tissues, it is somewhat variable (27). This may relate to its 
high lipid solubility or it may be a reflection of problems in accessing true 
values of O because of loss of the radioactive label from the molecule at 
long times (hours) after injection.  
14. A simple model which can be used to describe dispersion effects is given 
by the equation:                                                                                      
 Cm(t) = Ca(t) 8 kd exp (-kdW«««««(TXDWLRQ
where Cm(t) is the measured tracer concentration at the cannula outflow, 
Ca(t) is the inflow concentration and kd (min-1) is a dispersion constant, 
which is dependent on flow rate, length and internal diameter of the 
cannula and the interaction with blood on its internal surface. kd for a 
particular cannula and flow rate of blood can be calculated from Equation 
(5), if experiments are undertaken in vitro whereby the blood pumped 
through a cannula at a particular rate is switched rapidly between labelled 
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blood and unlabelled blood and the dispersion effect measured in the 
outflow. Results from such an experiment are presented in Table 2. Delay 
(td) can be estimated directly from the known volume of the cannula and 
the blood flow rate down the cannula. These values for kd  and td can be 
incorporated in Equation 2 to give a working form of the Equation: 
Ctiss(t) = (k1/kd)Cm(t+td) + (1-k2/kd)k1Cm(t+td) 8 exp(-k2W««(TXDWLRQ
(6) 
If dispersion effects are small i.e. large kd, then this Equation reduces to 
Equation 2. If dispersion effects are marked, i.e. small kd, then the 
Equation illustrates that failing to take dispersion effects into account has a 
marked effect on estimates of F. These issues were first quantitatively 
described by Meyer (38) (but note that a dispersion time constant 
equivalent to 1/kd was used in this case).  
 
15. In addition to using a short experimental time,T, errors associated with 
backflux in this technique are minimized if blood flow rate is low and there 
is a big accessible space in the tissue for the tracer (high D). Note that the 
short T gives the potential for large timing errors and great care must be 
taken to time the experiment accurately. As for the tissue equilibration 
technique, this means that blood flow to tissues needs to be stopped 
precisely at T. Interestingly, timing errors appear to be less of an issue 
with this technique than with the tissue equilibration technique for 
measurement of cerebral blood flow rate (28).  
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Figure Legends 
 
Figure 1 
Chemical structure of 4-Iodo[N-methyl-14C]antipyrine (a) and the compartmental 
model used for the quantitative estimation of F (b). When the extraction fraction, 
E, of a blood-borne tracer is 1.0, the rate constant k1 represents F. k2 represents 
the back-flux and Ca and Ctiss represent the arterial blood and tissue 
concentrations of the tracer respectively. In this model, the tissue is a single well-
mixed compartment.  
 
Figure 2 
Estimation of tissue blood flow rate (F) in the P22 rat sarcoma and several 
normal rat tissues using the tissue equilibration method with 125I-IAP (a) and 14C-
IAP (b). Results in panel a) were obtained by calculating Ctiss from gamma counts 
of large tissue samples. Data shows effects of the vascular disrupting agent 
combretastatin A4-P and the nitric oxide synthase inhibitor L-NNA plus the 
combination of the two. * represents a significant difference between treated and 
control untreated tumours.  The image in panel b) was obtained from an 
untreated P22 tumour by calculating multiple values for Ctiss from quantitative 
autoradiography of tumour sections. The mean F LVPOJ-1PLQ-1. The image 
in panel c) illustrates the vascular networks in the P22 tumour obtained by multi-
photon fluorescence microscopy. 
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Figure 1 
Tozer, Prise & Cunningham 
 
 
N
N
I
O CH3
CH3
k1 
k2 
C
Ctiss 
tissue 
blood 
a b) 
 30 
Figure 2 
Tozer, Prise and Cunningham 
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Table 1: Comparison of radiotracer methods for estimation of 
tissue blood flow rate (F) 
 
 
Tissue Equilibration Technique 
 
Indicator Fractionation Technique 
 
Requires blood vessel cannulation 
 
Requires blood vessel cannulation 
 
 
Time-consuming 
 
 
Relatively easy to perform 
 
 
Calculations require curve fitting 
algorithms 
 
 
Calculations require only a simple 
formula 
 
Backflux is taken into account in the 
model 
 
 
Very sensitive to errors associated with 
backflux 
 
Relatively sensitive to timing errors and 
delay & dispersion effects 
 
 
Reasonably tolerant of timing errors 
and delay & dispersion effects 
 
 
Reasonably tolerant of imprecision in O 
 
 
Tolerant of imprecision in O
 
 
Method of choice where O is well-
defined 
 
 
Method of choice where O is ill-defined, 
especially if F is low and D large 
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Table 2 : Example of expressions used to calculate the 
dispersion constant kd (min-1) from the linear speed (Qin cm per 
min) of blood flowing down various types of cannulae. These 
expressions were obtained by pumping blood at several known flow rates 
through each type of cannula and rapidly switching between labelled and 
unlabelled blood. The time-activity curves for the blood flowing out of the 
cannulae were compared with the known inflow time-activity curves, using 
Equation 5, to estimate kd for each condition. The relationship between kd and Q 
was described by the equation for a straight line, as shown. The cannulae used 
were prepared from PortexTM low density polyethylene tubing.
 
 
TYPE OF CANNULA  
 
200 mm length 
 
 
300 mm length 
 
0.50 mm internal diameter 
 
 
6.72 + 0.048*Q 
 
3.84 + 0.036*Q 
 
0.58 mm internal diameter 
 
 
9.54 + 0.040*Q 
 
-0.6 + 0.042*Q 
 
 
 
 
 
